Literature DB >> 23686275

The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii.

Pamela Alegranci1, Livia Carolina de Abreu Ribeiro, Lucas Souza Ferreira, Thais de Cássia Negrini, Danielle Cardoso Geraldo Maia, Aline Tansini, Amanda Costa Gonçalves, Marisa Campos Polesi Placeres, Iracilda Zeppone Carlos.   

Abstract

Sporotrichosis is a subcutaneous mycosis that is caused by the dimorphic fungus Sporothrix schenckii. This disease generally occurs within the skin and subcutaneous tissues, causing lesions that can spread through adjacent lymphatic vessels and sometimes leading to systemic diseases in immunocompromised patients. Macrophages are crucial for proper immune responses against a variety of pathogens. Furthermore, macrophages can play different roles in response to different microorganisms and forms of activation, and they can be divided into "classic" or "alternatively" activated populations, as also known as M1 and M2 macrophages. M1 cells can lead to tissue injury and contribute to pathogenesis, whereas M2 cells promote angiogenesis, tissue remodeling, and repair. The aim of this study was to investigate the roles of M1 and M2 macrophages in a sporotrichosis model. Toward this end, we performed phenotyping of peritoneal exudate cells and evaluated the concomitant production of several immunomediators, including IL-12, IL-10, TGF-β, nitric oxide, and arginase-I activity, which were stimulated ex vivo with cell wall peptide-polysaccharide. Our results showed the predominance of the M2 macrophage population, indicated by peaks of arginase-I activity as well as IL-10 and TGF-β production during the 6th and 8th weeks after infection. These results were consistent with cellular phenotyping that revealed increases in CD206-positive cells over this period. This is the first report of the participation of M2 macrophages in sporotrichosis infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23686275     DOI: 10.1007/s11046-013-9663-y

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  41 in total

Review 1.  The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation.

Authors:  Yoshiro Kobayashi
Journal:  J Leukoc Biol       Date:  2010-08-31       Impact factor: 4.962

Review 2.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

3.  Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production.

Authors:  Iñigo Angulo; María Belén Jiménez-Díaz; José Francisco García-Bustos; Domingo Gargallo; Federico Gómez de las Heras; María Angeles Muñoz-Fernández; Manuel Fresno
Journal:  Cell Immunol       Date:  2002 Jul-Aug       Impact factor: 4.868

4.  Disseminated sporotrichosis.

Authors:  Raúl Romero-Cabello; Alexandro Bonifaz; Raúl Romero-Feregrino; Carlos Javier Sánchez; Yancy Linares; Jorge Tay Zavala; Leticia Calderón Romero; Rodrigo Romero-Feregrino; José T Sánchez Vega
Journal:  BMJ Case Rep       Date:  2011-03-25

5.  Involvement of fungal cell wall components in adhesion of Sporothrix schenckii to human fibronectin.

Authors:  O C Lima; C C Figueiredo; J O Previato; L Mendonça-Previato; V Morandi; L M Lopes Bezerra
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 6.  Nitric oxide and T helper cell immunity.

Authors:  R C van der Veen
Journal:  Int Immunopharmacol       Date:  2001-08       Impact factor: 4.932

7.  Sporothrix schenckii and sporotrichosis.

Authors:  Leila M Lopes-Bezerra; Armando Schubach; Rosane O Costa
Journal:  An Acad Bras Cienc       Date:  2006-05-11       Impact factor: 1.753

8.  Dual role for nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility.

Authors:  Flávia R F Nascimento; Vera L G Calich; Dunia Rodríguez; Momtchilo Russo
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

9.  Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha.

Authors:  I Z Carlos; D B G Sgarbi; G C Santos; M C P Placeres
Journal:  Scand J Immunol       Date:  2003-03       Impact factor: 3.487

10.  Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype.

Authors:  Shikha Bhatia; Mingjian Fei; Manohar Yarlagadda; Zengbiao Qi; Shizuo Akira; Shinobu Saijo; Yoichiro Iwakura; Nico van Rooijen; Gregory A Gibson; Claudette M St Croix; Anuradha Ray; Prabir Ray
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

View more
  6 in total

1.  Response of Cytokines and Hydrogen Peroxide to Sporothrix schenckii Exoantigen in Systemic Experimental Infection.

Authors:  Danielle Cardoso Geraldo Maia; Amanda Costa Gonçalves; Lucas Souza Ferreira; Francine Alessandra Manente; Deivys Leandro Portuondo; José Carlos Rebuglio Vellosa; Marisa Campos Polesi; Alexander Batista-Duharte; Iracilda Zeppone Carlos
Journal:  Mycopathologia       Date:  2015-11-24       Impact factor: 2.574

Review 2.  Molecular Components of the Sporothrix schenckii Complex that Induce Immune Response.

Authors:  Carlos A Alba-Fierro; Armando Pérez-Torres; Conchita Toriello; Yolanda Romo-Lozano; Everardo López-Romero; Estela Ruiz-Baca
Journal:  Curr Microbiol       Date:  2016-04-27       Impact factor: 2.188

3.  Acute Penicillium marneffei infection stimulates host M1/M2a macrophages polarization in BALB/C mice.

Authors:  Xiaoying Dai; Congzheng Mao; Xiuwan Lan; Huan Chen; Meihua Li; Jing Bai; Jingmin Deng; Qiuli Liang; Jianquan Zhang; Xiaoning Zhong; Yi Liang; Jiangtao Fan; Honglin Luo; Zhiyi He
Journal:  BMC Microbiol       Date:  2017-08-18       Impact factor: 3.605

Review 4.  Immunopathogenesis of Human Sporotrichosis: What We Already Know.

Authors:  Fatima Conceição-Silva; Fernanda Nazaré Morgado
Journal:  J Fungi (Basel)       Date:  2018-07-31

5.  Murine Macrophage Requires CD11b to Recognize Talaromyces marneffei.

Authors:  Yongxuan Hu; Sha Lu; Liyan Xi
Journal:  Infect Drug Resist       Date:  2020-03-27       Impact factor: 4.003

6.  Is There Any Difference between the In Situ and Systemic IL-10 and IFN-γ Production when Clinical Forms of Cutaneous Sporotrichosis Are Compared?

Authors:  Fernanda N Morgado; Armando O Schubach; Maria Inês Pimentel; Marcelo R Lyra; Érica C F Vasconcellos; Claudia M Valete-Rosalino; Fátima Conceição-Silva
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.